Josep María Echarri Torres

Managing Partner at Inveready Asset Management SGEIC SA

Josep María Echarri Torres

Josep María Echarri Torres

Managing Partner at Inveready Asset Management SGEIC SA

Overview
Career Highlights

Neurotec Pharma SL
Inveready Capital Co. SL
Inveready Asset Management SGEIC SA

RelSci Relationships

428

Number of Boards

8

Birthday

01/1976

Age

45

Contact Data
Trying to get in touch with Josep María Echarri Torres? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Josep María Echarri Torres likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Althia Health SL

Relationship likelihood: Strong

Founder & Chief Executive Officer at Oryzon Genomics SA

Relationship likelihood: Strong

Chairman at Grupo Natac SL

Relationship likelihood: Strong

Chief Executive Officer at Palo Biofarma SL

Relationship likelihood: Strong

Vice Chairman at Grupo Natac SL

Relationship likelihood: Strong

Managing Partner at Inveready Asset Management SGEIC SA

Relationship likelihood: Strong

Co-Founder at Ability Pharmaceuticals SL

Relationship likelihood: Strong

Chief Executive Officer & Director at Euskaltel SA

Relationship likelihood: Strong

Executive President at Althia Health SL

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at Althia Health SL

Relationship likelihood: Strong

Paths to Josep María Echarri Torres
Potential Connections via
Relationship Science
You
Josep María Echarri Torres
Managing Partner at Inveready Asset Management SGEIC SA
Education
Class of 2002

ESADE Business School provides a modern, innovative, and inherently digitalised learning experience geared towards training leaders.

ESADE is an international academic institution with over fifty years of history. The main asset of this business school are people: faculty members and professionals who nurture reflection, dialogue, projects and initiatives to ensure excellent education, pioneering research and a valuable contribution to social debate and transformation. ESADE's key mission is to train individuals to become highly-competent professionals fully aware of their social responsibility. We promote education and research through our Law School and Business School with a firm commitment to intellectual rigour, critical analysis and academic excellence. The vast majority of ESADE's almost 40,000 alumni are ambassadors of these values in over one hundred countries and hold top-level posts in companies, public administration and the non-profit sector. ESADE's global prestige stems from its quality education, its international focus and its holistic approach towards professional and personal skills development. Throughout the years, ESADE has forged deep-rooted ties with the business, economic and social sectors as a platform for education and innovation, as a benchmark research centre and as a stage for reflection and dialogue. What's more, ESADE actively seeks out innovative solutions to the challenges of human resource and knowledge management, corporate innovation and globalisation, entrepreneurship and corporate social responsibility, as well as the solution of legal problems related to new business challenges. I'd like to welcome you to our website, where you can discover details of our programmes, faculty and campus life. And should you decide, it would be our pleasure to work with you personally in the pursuit of your personal and professional goals.

Unknown

University of Barcelona is the most formidable public institution of higher education in Catalonia, catering to the needs of the greatest number of students and delivering the broadest and most comprehensive offering in higher educational courses. The UB is also the principal centre of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programmes it conducts and the excellence these have achieved.

Career History
Director
2010 - Current

Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain.

Director
2010 - Current

Grupo Natac SL is a holding company engaged in the development, manufacture, and commercialization of natural, plant-derived ingredients. These find applications in the pharmaceutical, nutraceutical, food and beverage, cosmetics, and animal nutrition sectors. The company was founded by Jose Carlos Quintela and Antonio Angel Delgado on October 27, 2010, and is headquartered in Boadilla del Monte, Spain.

Managing Partner
2008 - Current

INVEREADY is an active manager which invests in innovative companies in the biotech, medical equipment, nanotechnology, renewable energy, advanced software and ICT sectors. Their geographic focus is on Spain.The firm seeks to participate in first rounds of financing, making maximum direct investments of EUR 100,000-500,000, which is usually supplemented by public funds for innovative technology companies and other private resources. The typically take minority and significant minority stakes in their investee companies and expect to hold investments for five to eight years.INVEREADY provides advice on preparing financial plans and optimizing business plans, finding investors for seed-stage financing, structuring capital searches, advice in contract negotiations, negotiation and management of various public financing instruments for innovative companies such as CDTI NEOTEC, ENISA, ICF, EUROCAN, PROFIT, Ayudas Autonómicas, participation in the CENIT program or other European programs.

Boards & Committees
Director
2021 - Current

Euskaltel SA engages in rendering, management, installation, operation and marketing and sale of telecommunications networks and services. It operates through the following segments: Mass market, Business, and Wholesale. The Mass market segment provides fixed-line and mobile telecommunication services, as well as other added-value services which it renders through its fibre optic network and the virtual mobile operator agreement. The Business segment gives fixed and mobile telecommunication services to Small and Home Offices, Small and Medium Enterprises, and Large Accounts. The Wholesale segment provides services that include line access, and voice and data services to other operators in the telecommunications sector. The company was founded on July 3, 1995 and is headquartered in Derio, Spain.

Independent Director
2020 - Current

Aspy Global Services SA is a holding company, which participates in the capital of resident and non-resident entities in Spanish territory, directing and managing said participations. The company was founded on April 24, 2015 and is headquartered in Badalona, Spain.

External Director
2019 - Current

Parlem Telecom Companyia de Telecomunicacions SA engages in the provision and operation of telecommunication services. The firm specializes in comprehensive mobile telephony, internet, fixed telephony, and television services. The company was founded by Ernest Perez-Mas on July 30, 2012 and is headquartered in Barcelona, Spain.

Investments
Details Hidden

Grupo Natac SL is a holding company engaged in the development, manufacture, and commercialization of natural, plant-derived ingredients. These find applications in the pharmaceutical, nutraceutical, food and beverage, cosmetics, and animal nutrition sectors. The company was founded by Jose Carlos Quintela and Antonio Angel Delgado on October 27, 2010, and is headquartered in Boadilla del Monte, Spain.

Details Hidden

Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain.

Details Hidden

Oryzon Genomics SA is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. It focuses on epigenetics in various therapeutic indications, with a special emphasis on oncology and neurodegenerative disease. The firm's product pipelines include Iadademstat and Vafidemstat. The company was founded by Carlos Manuel Buesa Arjol and Tamara Maes on June 2, 2000 and is headquartered in Barcelona, Spain.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Josep María Echarri Torres. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Josep María Echarri Torres's profile does not indicate a business or promotional relationship of any kind between RelSci and Josep María Echarri Torres.